❌

Reading view

Gated Relational Alignment via Confidence-based Distillation for Efficient VLMs

arXiv:2601.22709v4 Announce Type: replace-cross Abstract: Vision-Language Models (VLMs) achieve strong multimodal performance but are costly to deploy, and post-training quantization often causes significant accuracy loss. Despite its potential, quantization-aware training for VLMs remains underexplored. We propose GRACE, a framework unifying knowledge distillation and QAT under the Information Bottleneck principle: quantization constrains information capacity while distillation guides what to preserve within this budget. Treating the teacher as a proxy for task-relevant information, we introduce confidence-gated decoupled distillation to filter unreliable supervision, relational centered kernel alignment to transfer visual token structures, and an adaptive controller via Lagrangian relaxation to balance fidelity against capacity constraints. Across extensive benchmarks on LLaVA and Qwen families, our INT4 models consistently outperform FP16 baselines (e.g., LLaVA-1.5-7B: 70.1 vs. 66.8 on SQA; Qwen2-VL-2B: 76.9 vs. 72.6 on MMBench), nearly matching teacher performance. Using real INT4 kernel, we achieve 3$\times$ throughput with 54% memory reduction. This principled framework significantly outperforms existing quantization methods, making GRACE a compelling solution for resource-constrained deployment. Code and data are available at: https://github.com/ForeverBlue816/GRACE.
  •  

PanLUNA: An Efficient and Robust Query-Unified Multimodal Model for Edge Biosignal Intelligence

arXiv:2604.04297v1 Announce Type: new Abstract: Physiological foundation models (FMs) have shown promise for biosignal representation learning, yet most remain confined to a single modality such as EEG, ECG, or PPG, largely because paired multimodal datasets are scarce. In this paper, we present PanLUNA, a compact 5.4M-parameter pan-modal FM that jointly processes EEG, ECG, and PPG within a single shared encoder. Extending LUNA's channel-unification module, PanLUNA treats multimodal channels as entries in a unified query set augmented with sensor-type embeddings, enabling efficient cross-modal early fusion while remaining inherently robust to missing modalities at inference time. Despite its small footprint, PanLUNA matches or exceeds models up to 57$\times$ larger: 81.21% balanced accuracy on TUAB abnormal EEG detection and state-of-the-art 0.7416 balanced accuracy on HMC multimodal sleep staging. Quantization-aware training with INT8 weights recovers $\geq$96% of full-precision performance, and deployment on the GAP9 ultra-low-power RISC-V microcontroller for wearables achieves 325.6 ms latency and 18.8 mJ per 10-second, 12-lead ECG inference, and 1.206 s latency at 68.65 mJ for multimodal 5-channel sleep staging over 30-second epochs.
  •  

A Review of the Role of Zeqi Decoction in the Treatment of Non-Small Cell Lung Cancer

J Multidiscip Healthc. 2026 Mar 11;19:584071. doi: 10.2147/JMDH.S584071. eCollection 2026.

ABSTRACT

Non-small cell lung cancer (NSCLC) is one of the malignant tumors with the highest incidence and mortality rates. Zeqi Decoction has the functions of "promoting diuresis and reducing swelling, resolving phlegm and dispersing nodules", embodying the unique approach of traditional Chinese medicine in treating lung cancer by "strengthening the body's resistance and eliminating pathogenic factors". Modern research shows that Zeqi Decoction exerts anti-NSCLC effects through multiple pathways and targets. In terms of the material basis of its efficacy, its active ingredients (such as diterpene esters and flavonoids contained in Zeqi) have the ability to directly inhibit the proliferation, invasion and migration of tumor cells and induce apoptosis. In terms of the mechanism of action, basic experiments have revealed that Zeqi Decoction can down-regulate the S100A9/STAT3 signaling pathway, inhibit the immunosuppressive activity of myelium-derived suppressor cells (MDSCs), reshape the tumor microenvironment, thereby enhancing the cytotoxic function of CD8⁺T cells, and can also regulate the EGFR/PI3K/Akt pathway to affect PD-L1 expression. Intervene in tumor immune escape; In terms of clinical transformation, the combination of Zexi Decoction with chemotherapy and targeted therapy can improve patients' symptoms such as cough and pleural effusion, prolong progression-free survival, and alleviate the toxic and side effects of Western medical treatment. In addition, Zexi Decoction also shows potential value in reversing drug resistance such as gemcitabine. At present, there are still problems such as the lack of standardized protocols and unclear molecular mechanisms in the research. In the future, it is necessary to combine new technologies such as network pharmacology and multi-omics analysis to deepen the research on the pharmacological material basis, dose-effect relationship and evidence-based medicine of Zeqi Decoction, so as to promote the clinical application and transformation of the combination of traditional Chinese and Western medicine in the treatment of NSCLC.

PMID:41847115 | PMC:PMC12991379 | DOI:10.2147/JMDH.S584071

  •  
❌